| Date Filed | Type | Description |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/13/2023 |
8-K
| Other Events Interactive Data |
| 02/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/28/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 5.9% stake in Crinetics Pharmaceuticals Inc. |
| 02/14/2023 |
SC 13G
| BRAIDWELL LP reports a 6.4% stake in CRINETICS PHARMACEUTICALS INC |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 5.1% stake in Crinetics Pharmaceuticals, Inc. |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 10.4% stake in Crinetics Pharmaceuticals, Inc. |
| 02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.3% stake in Crinetics Pharmaceuticals, Inc. |
| 01/27/2023 |
5
| Wilson Marc (CFO) has filed a Form 5 on Crinetics Pharmaceuticals, Inc. |
| 01/27/2023 |
5
| Krasner Alan Seth (Chief Medical Officer) has filed a Form 5 on Crinetics Pharmaceuticals, Inc. |
| 01/27/2023 |
5
| Knight Jeff E. (COO) has filed a Form 5 on Crinetics Pharmaceuticals, Inc. |
| 01/09/2023 |
8-K
| Quarterly results |
| 11/28/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
8-K
| Quarterly results |
| 10/13/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 10/03/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/12/2022 |
8-K
| Quarterly results |
|